In the realm of clinical trials, it’s easy to gravitate towards experienced sites with a long track record. Established sites have proven systems, experienced staff, and a history of successful studies, making them a seemingly safe choice. However, research-naïve sites offer a wealth of untapped potential and should not be overlooked. These newer sites bring fresh energy, innovative approaches, and a strong commitment to expanding their capabilities. By embracing research-naïve sites, sponsors can discover hidden gems that contribute significantly to the advancement of medical science and the success of clinical trials.
So, don’t overlook research-naïve sites. Here’s why:
- Highly Experienced and Strong Performing Doctors: Many research-naïve sites are home to highly experienced physicians who are eager to expand their horizons into clinical research. These doctors bring with them a wealth of clinical knowledge and a strong track record in patient care, making them valuable assets in the research field.
- Willingness to Further Train: Physicians at research-naïve sites are often highly motivated to undergo additional training to become research-ready. This enthusiasm can translate into meticulous adherence to study protocols and a fresh perspective on clinical research. All of Medovation Clinical Research PI’s have undergone GCP training as well as 1:1 training with our highly experienced Medical Director, setting them up for success from the start.
- Patient Availability & Diversity: Unlike more established research sites that juggle multiple studies, research-naïve sites often have a more available patient pool. This can lead to faster recruitment times and higher retention rates, as patients are not divided among numerous concurrent studies. In addition, their patient base brings a great mix of diversity.
- Strong Patient Relationships: Physicians at these sites typically have longstanding relationships with their patients. This trust and rapport can result in patients being 84% more likely to engage in clinical trials, ensuring better compliance and data integrity.
- Qualifications of the Study Team: The qualifications of the Principal Investigator (PI) should be considered alongside the extensive experience of the study team. At Medovation Clinical Research, the combined expertise of the team exceeds 50 years, bringing a depth of knowledge and dedication to the study.
By considering these factors, sponsors can uncover high-performing sites with dedicated professionals and eager patient populations, ultimately enhancing the success of their clinical trials.